Tumor Marker Blood Test in Pallas Clinic

A tumor marker blood test at Pallas Clinic in Jūrmala, Latvia, screens for specific substances that may indicate cancer activity. This diagnostic tool helps track the growth of certain tumors or how well a patient responds to ongoing therapy. The clinic provides this examination as part of its oncology supportive care, using lab analysis to detect markers for prostate, ovarian, colorectal, and liver cancers.

Test details and markers

The procedure requires a standard blood sample to identify proteins or other substances produced by cancer cells. Patients receive results that monitor various conditions through specific markers.

• PSA. Checks for prostate-specific antigen to screen for prostate cancer.
• CA-125. Measures levels often associated with ovarian and endometrial cancer.
• CEA. Identifies carcinoembryonic antigen, commonly used for colorectal cancer tracking.
• AFP. Screens for alpha-fetoprotein, which can indicate liver or testicular cancer.

Purpose and setting

This test serves as a secondary tool for early detection and disease staging. It is performed in an outpatient setting, and the findings help clinicians adjust care plans based on how the tumor reacts to interventions. The results provide data on whether a cancer is growing, staying the same, or shrinking during treatment. Once the lab completes the analysis, patients should discuss the specific numbers with a specialist to integrate them into their overall medical records. You can request a consultation for this diagnostic through Bookimed.